![Simon Douglas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Douglas
Presidente presso
FUSION ANTIBODIES PLC
Patrimonio netto: 146 105 $ in data 31/08/2026
Profilo
Dr. Simon G.
Douglas is a Chairman at EMQN CIC, a Non-Executive Chairman at C-Major Ltd. and a Non-Executive Chairman at Fusion Antibodies Plc.
Dr. Douglas was previously employed as a Non-Executive Chairman by Abselion Ltd., a Non-Executive Chairman by Cambridge Nutritional Sciences Plc, a Chief Executive Officer & Director by Biofortuna Ltd., an Executive Chairman by Lab901 Ltd., a Managing Director by Invitrogen Holdings Ltd., a Chief Executive Officer by DNA Research Innovations Ltd., a Chief Executive Officer by DRI Ltd. (United Kingdom), a Chief Executive Officer by Tepnel Life Sciences Plc, a Head-Technical & Marketing by ICI Group, a Project Leader by GE Healthcare Ltd. (United Kingdom), and a Manager-Business Development by Zeneca, Inc. He received his graduate degree from The University of Southampton and a doctorate degree from The University of Southampton.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/02/2026 | 861.062 ( 0,69% ) | 146 105 $ | 31/08/2026 |
Posizioni attive di Simon Douglas
| Società | Posizione | Inizio |
|---|---|---|
| FUSION ANTIBODIES PLC | Presidente | 01/09/2011 |
C-Major Ltd.
 C-Major Ltd. Internet Software/ServicesTechnology Services Develops online platform which produces medical devices to reduce the risk of needle stick injuries | Presidente | 01/09/2019 |
Precedenti posizioni note di Simon Douglas
| Società | Posizione | Fine |
|---|---|---|
HexagonFab Ltd.
 HexagonFab Ltd. Medical SpecialtiesHealth Technology Develops practical measurement tools that helps scientists | Presidente | 23/03/2026 |
| CAMBRIDGE NUTRITIONAL SCIENCES PLC | Presidente | 22/04/2024 |
Biofortuna Ltd.
 Biofortuna Ltd. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and diagnostics development and contract manufacturing solutions | Amministratore Delegato | 01/01/2019 |
Lab901 Ltd.
 Lab901 Ltd. Medical SpecialtiesHealth Technology Develops and manufactures laboratory processing products | Presidente | 01/01/2011 |
Invitrogen Holdings Ltd.
 Invitrogen Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Amministratore Delegato | 01/01/2006 |
Formazione di Simon Douglas
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Researches and develops medical diagnostic products | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNA Research Innovations Ltd.
 DNA Research Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Conducts DNA based research | Commercial Services |
Lab901 Ltd.
Lab901 Ltd. Medical SpecialtiesHealth Technology Develops and manufactures laboratory processing products | Health Technology |
Cambridge Nutritional Sciences Plc
 Cambridge Nutritional Sciences Plc Medical SpecialtiesHealth Technology Engages in selling of medical products, primarily in the immunoassay, in-vitro diagnostics market | Health Technology |
ICI Group
 ICI Group Industrial SpecialtiesProcess Industries Manufactures paints & coatings | Process Industries |
Zeneca, Inc. | |
Fusion Antibodies Plc
 Fusion Antibodies Plc Medical/Nursing ServicesHealth Services Develops antibody-based therapeutic products | Health Services |
Invitrogen Holdings Ltd.
Invitrogen Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Biofortuna Ltd.
Biofortuna Ltd. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and diagnostics development and contract manufacturing solutions | Commercial Services |
C-Major Ltd.
C-Major Ltd. Internet Software/ServicesTechnology Services Develops online platform which produces medical devices to reduce the risk of needle stick injuries | Technology Services |
HexagonFab Ltd.
HexagonFab Ltd. Medical SpecialtiesHealth Technology Develops practical measurement tools that helps scientists | Health Technology |
DRI Ltd. (United Kingdom) |
